A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain

NCT00410644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

463

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Analgesics
Opioid

Interventions

DRUG: OROS Hydromorphone HCI

Sponsor

Alza Corporation, DE, USA